5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy

Questions about this coverage

How did the left and right cover 5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy?

Of the 133 outlets on this story carrying a published leaning rating, 35% are rated left, 48% are rated centre, 17% are rated right. Those percentages are shares of the rated outlets, not of every outlet that ran it, which was 184. The sections above set out what each side emphasised, in its own terms.

Is 5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy left or right?

Neither side dominates it. Of the 133 rated outlets on this story, 35% are rated left, 48% are rated centre, 17% are rated right, and no side holds the 70% this site would want before calling a field one-sided. A story is not left or right in any case; the outlets that carried it are what carry ratings.

Is the coverage of 5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy biased?

5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy is one event reported by 184 outlets, and this page does not rate the story as biased or unbiased. What it publishes is the spread: which outlets ran it, where named rating organisations place each of them on the spectrum, and what each side chose to lead with. A leaning rating describes an outlet's record over time, not this article, and the two should not be run together.

Which side is not reporting 5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy?

When we first saw this story, outlets rated right had barely covered it. Coverage accretes for hours after an event, so that is where to look rather than a verdict — the split above is the current count, and it is the one to read.

Which outlets covered 5th Circuit to Hear Louisiana Challenge to Federal Abortion‑Pill Policy?

184 that we know of, every one of them listed further up this page with a link to its own report and to what we hold on the publisher. Nothing here is a summary of somebody else's summary: the outlets are named so the original reporting can be read.

What case will the 5th Circuit hear?

The 5th Circuit will hear Louisiana et al. v. Food and Drug Administration, a lawsuit that challenges the federal policy allowing mifepristone to be prescribed via telehealth without an in‑person visit. The hearing is set for Wednesday before a three‑judge panel in New Orleans.

What policy is Louisiana trying to change?

Louisiana seeks to overturn the Biden‑era rule that permits abortion pills, specifically mifepristone, to be prescribed without an in‑person medical visit. The state argues that the policy should be tightened, effectively ending remote telehealth prescriptions for the medication.

When will the arguments be heard?

The arguments will be heard on Wednesday, with a three‑judge panel of the 5th U.S. Circuit Court of Appeals convening in New Orleans to consider Louisiana’s challenge to the federal abortion‑pill policy.

How common is medication abortion now?

Medication abortion has become the most common form of abortion in the United States since the Supreme Court’s 2022 decision overturning Roe v. Wade. Throughout that period, prescriptions for abortion pills delivered through telehealth have continued to rise.